Veristat to Speak at Access Pharma’s Upcoming Clinical Research Career Day in Montreal - Feb 4
February 1, 2016
Veristat to Exhibit at the Outsourcing in Clinical Trials West Coast 2016 Conference
January 14, 2016
Veristat to sponsor/exhibit at the 5th Annual CROWN Congress | Clinical Research & Operations Worldwide Networking
January 4, 2016
Join Veristat and the industry’s elite clinical decision-makers to learn, network and discuss topics critical to the effective development, management and execution of clinical trials. Let’s assess the latest strategies, trends, tools and technologies for advancing clinical trials.
Join Veristat and the world’s leading biotechnology and life sciences firms at one of the industry’s largest annual healthcare investor events of 2016.
Join Veristat at the 2015 CDISC International Interchange conference which is themed "Smarter Research to Unlock Cures".
Veristat to Attend the Chief Medical Officer Summit West
October 29, 2015
Join Veristat at the 3rd Annual Chief Medical Officer Summit West, which is said to be “the only conference of its kind dedicated to addressing the unique challenges faced by CMOs in emerging biotechnology firms”.
Visit Veristat Booth #8 at the Outsourcing in Clinical Trials Southern California Conference
Learn How to Work Smarter With your Clinical Research Partners at MAGI 2015
Veristat is excited to attend and exhibit at the upcoming Outsourcing in Clinical Trials New England conference, taking place on September 16-17, 2015 in Boston, MA. We encourage you to stop by our booth to speak with our experts about your current needs and challenges.
Veristat to Talk on “Use of Biomarkers in Clinical Development & Regulatory Submission” at MassBio Forum.
July 29, 2015
Veristat’s President and Chief Biostatistician, John P. Balser, PhD will moderate the second in a two-part series of panel discussions on Biomarkers at the upcoming MassBio Forum taking place on Tuesday, August 4, 2015 from 8:00-10:00 AM. This second forum will focus on the use of biomarkers in clinical development, with specific discussion on clinical study design, patient selection, statistical analysis, and the regulatory challenges with using biomarkers.
The panel will explore the following: